Role of inflammation in childhood epilepsy and ADHD comorbidity

Appl Neuropsychol Child. 2022 Jul-Sep;11(3):291-296. doi: 10.1080/21622965.2020.1807982. Epub 2020 Aug 25.

Abstract

Epilepsy is a heterogeneous disorder that is not limited to experiencing seizures but also includes multiple neuropsychiatric squeal (i.e. attention-deficit/hyperactivity disorder (ADHD), depression and anxiety) that adversely impact a child quality of life. However, the underlying mechanism linking both disorders is not yet thoroughly explored. Our objective was to assess pro-inflammatory cytokines levels in children with seizure controlled epilepsy and explore the association between pro-inflammatory cytokines and the co-occurrence of ADHD in such children. A cross-sectional study included 50 children with controlled epilepsy for at least one year, in addition to 30 neurotypical children as controls. All children were assessed by the Conner parent scale for ADHD. Serum interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) levels were measured and correlated to clinical data. In the present study, 23 out of 50 children with epilepsy also had ADHD (46%). Children with ADHD have been found to have a significantly lower age of onset, longer duration of epilepsy, and a higher serum level of IL-6 and TNF-α than those without ADHD. The Conner's parent rating scale overall total score yielded significant negative correlations with the age of onset of epilepsy and a significant positive correlation with the duration of epilepsy and pro-inflammatory cytokine levels. In addition to active seizures, the presence of elevated circulating inflammation markers may be associated with increased frequency of ADHD in children with epilepsy aged 6-14 years.

Keywords: ADHD; children; epilepsy; inflammation.

MeSH terms

  • Attention Deficit Disorder with Hyperactivity* / psychology
  • Child
  • Comorbidity
  • Cross-Sectional Studies
  • Epilepsy* / complications
  • Humans
  • Inflammation / complications
  • Inflammation / epidemiology
  • Interleukin-6
  • Quality of Life
  • Seizures / complications
  • Tumor Necrosis Factor-alpha

Substances

  • Interleukin-6
  • Tumor Necrosis Factor-alpha